SCHEMBL30148554

SCHEMBL30148554

CNc1ccc(O[Si](C)(C)C(C)(C)C)c(CC(=O)N(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.38
POLB P06746 1/20 0.34
ALDH1A1 P00352 4/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
KDM4E B2RXH2 2/20 0.31
HPGD P15428 2/20 0.31
HSD17B10 Q99714 2/20 0.31
NPC1 O15118 1/20 0.31
CYP1A2 P05177 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
RAB9A P51151 1/20 0.31
KCNK2 O95069 1/20 0.30
KCNA5 P22460 1/20 0.30
KCNH2 Q12809 1/20 0.30
KCNB1 Q14721 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30772197 0.80 HSD17B10 (0.44) POLBALDH1A1MEN1KMT2AKDM4E
SCHEMBL24802505 0.80 HSD17B10 (0.44) POLBALDH1A1MEN1KMT2AKDM4E
SCHEMBL24803754 0.80 KDM4E (0.31) ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL30148685 0.79 MEN1 (0.43) POLBALDH1A1MEN1KMT2AKDM4E
SCHEMBL28882452 0.74 DRD2 (0.34) DRD2
SCHEMBL30148651 0.73 EGFR (0.43) ALDH1A1
SCHEMBL24804875 0.72 NR1H4 (0.44) POLBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL2401781 0.69 DRD2 (0.43) DRD2POLBALDH1A1SMN1; SMN2MEN1
SCHEMBL24803291 0.68 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2KDM4ECYP1A2CYP2C19
SCHEMBL30772199 0.68 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2KDM4ECYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117580836-A Pyrimidine ring structure derivative and application thereof 四川汇宇制药股份有限公司 2024-02-20 CN disclosed
WO-2022268209-A1 DERIVATIVE HAVING PYRIMIDINE-FUSED CYCLIC STRUCTURE, AND USE THEREOF 四川汇宇制药股份有限公司 2022-12-29 WO disclosed